With 24,058 new patients added in Q3 2018 after the acquisition of CanniMed (CMMDF) and reporting 211% revenue growth in Q3 2018, Aurora Cannabis (ACBFF) is growing its business at a high pace. Additionally, the financial position seems very stable, which the market seems to appreciate. With that, the main issue on this name is the valuation. The company is trading at 92x sales, which seems expensive as compared to other peers. In addition, the marijuana industry also trades at very high valuations of 25-92x forward sales. For how long can investors justify
Get Real-Time Updates from MJobserver.com